In the United States, there is growing momentum on a national scale to develop precision medicine for many disease states, including ischemic stroke. The best example of an established use of precision medicine is in the field of oncology. Treatment regimens for individual patients may now be tailored to the molecular genetics of the tumors. President Obama called for the development of a precision medicine initiative in January 2015. In response to the President, the National Institutes of Health announced the Precision Medicine Initiative Cohort Program, a large-scale database of health information to inform understanding of the interplay between health and an individual’s genotype.
Rostanski SK, Marshall RS. Precision Medicine for Ischemic Stroke. JAMA Neurol. 2016;73(7):773-774. doi:10.1001/jamaneurol.2016.0087